Our Development Pipeline

BPX-01

Topical Minocycline, 2%

BPX-01 (topical minocycline, 2%) is being developed for the treatment of moderate-to-severe acne. In a Phase 2b study, treatment with BPX-01 showed a statistically significant reduction in the number of acne lesions, with no serious adverse events related to study treatment. BPX-01 is a hydrophilic topical gel with fully solubilized minocycline capable of penetrating the skin to deliver the antibiotic to where acne develops in the pilosebaceous unit..

Timber Pipeline 08-10-20.png

If you are interested in any of Timber’s ongoing clinical research programs, please contact trials@timberpharma.com.